Swiss SMI rises 5.1% in October, beating Euro Stoxx 50 by 7.5 points
The Swiss SMI was up about 5.1% in October, against a 2.4% decline in the Euro Stoxx 50, a 7.5 percentage point gap, the widest since March 2020. Roche, Novartis and Nestlé gained 13%, 9% and 10% in the month. The text attributes this resilience to the weight of healthcare, financials, industrials and consumer staples in the Swiss market, to the franc as a safe-haven currency and to official rates at 0%.
In 40 seconds
- The SMI rose about 5.1% in October versus a 2.4% drop in the Euro Stoxx 50, a 7.5 point gap, the widest since March 2020
- Roche, Novartis and Nestlé posted monthly gains of 13%, 9% and 10%, respectively
- At the end of September, healthcare accounted for about 38.6% of the MSCI Switzerland, financials 20%, industrials 13.3% and consumer staples 13%
IASummary generated by artificial intelligence from a story by XTB.com. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.